Intersect ENT (XENT) Tops Q3 EPS by 10c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. QGEN
5. QS
6. BFH
7. BRO
8. SAP
9. RCUS
10. LMT

Go back to Intersect ENT (XENT) Tops Q3 EPS by 10c

Intersect ENT Reports Third Quarter 2020 Financial Results

November 2, 2020 7:00 AM EST

MENLO PARK, Calif.--(BUSINESS WIRE)-- Intersect ENT, Inc. (Nasdaq: XENT), a company transforming care for patients with ear, nose and throat (ENT) conditions, today reported financial results for the third quarter ended September 30, 2020.

Third Quarter 2020 Overview

Revenue of $22.7 million in the third quarter of 2020, compared to $24.1 million in the third quarter of 2019
Strong sales trend reinforces confidence in fourth quarter 2020 sequential revenue growth
Cash, Cash Equivalents and Short-term Investments of $130.7 million

Total revenue was $22.7 million for the third quarter of 2020, compared to... More